Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced persisting amnestic disorder
ICD-10 F13.96 is a billable code used to indicate a diagnosis of sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced persisting amnestic disorder.
F13.96 refers to a condition characterized by the use of sedative, hypnotic, or anxiolytic substances that leads to a persisting amnestic disorder. This disorder is marked by significant memory impairment that persists beyond the period of intoxication or withdrawal. Patients may exhibit difficulties in forming new memories or recalling previously learned information, which can severely impact their daily functioning. The use of these substances can lead to addiction, where individuals develop a psychological and physical dependence on the drugs. Withdrawal symptoms can include anxiety, tremors, and seizures, while intoxication may present with drowsiness, confusion, and impaired coordination. Treatment often involves a combination of detoxification, behavioral therapies, and support groups to address both the substance use disorder and the cognitive impairments associated with the amnestic disorder.
Comprehensive mental health evaluations, including substance use history and cognitive assessments.
Patients presenting with memory loss and a history of sedative use, requiring assessment for dual diagnosis.
Ensure clear documentation of both substance use and cognitive impairments to support the diagnosis.
Detailed treatment plans, including detoxification protocols and follow-up care.
Patients undergoing detoxification from sedatives with associated cognitive deficits.
Document the treatment response and any changes in cognitive function during recovery.
Used during initial evaluation of a patient with suspected substance use disorder and cognitive impairment.
Detailed assessment notes including substance use history and cognitive evaluations.
Psychiatric evaluations should include specific inquiries about memory and cognitive function.
The 'persisting amnestic disorder' indicates that the cognitive impairments are not temporary and require ongoing treatment and management, distinguishing it from other substance use disorders without cognitive effects.
